Bartlett & Co Wealth Management’s 2seventy bio TSVT Stock Holding History
Bought
Maintained
Sold
Other funds holding TSVT
BCM
NM
BBA
CC
Bartlett & Co Wealth Management's TSVT Position: Q1 2025 in Review
Bartlett & Co Wealth Management sold out of 2seventy bio (TSVT) in Q1 2025, closing a stake of 33 shares — an estimated $97 sold.
Bartlett & Co Wealth Management first reported a position in TSVT in Q1 2022 and held it in 12 quarters. The position peaked at $563 in Q1 2022. 139 funds tracked by Wall St. Rank hold TSVT as of Q1 2025.
- Bartlett & Co Wealth Management reported no remaining 2seventy bio position as of Q1 2025 after selling out during the quarter.
- Bartlett & Co Wealth Management sold 33 2seventy bio shares in Q1 2025, an estimated $97.
- Bartlett & Co Wealth Management first reported a position in 2seventy bio in Q1 2022 and held it in 12 quarters.
- Bartlett & Co Wealth Management's 2seventy bio position peaked at $563 in Q1 2022.
- 139 funds tracked by Wall St. Rank held 2seventy bio as of Q1 2025.
Based on Bartlett & Co Wealth Management's 13F filing for Q1 2025, filed 24 Apr 2025.